Csilla Pelyhe
Overview
Explore the profile of Csilla Pelyhe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kovacshazi C, Hambalko S, Sayour N, Gergely T, Brenner G, Pelyhe C, et al.
Sci Rep
. 2024 May;
14(1):12016.
PMID: 38797778
Hypercholesterolemia (HC) induces, propagates and exacerbates cardiovascular diseases via various mechanisms that are yet not properly understood. Extracellular vesicles (EVs) are involved in the pathomechanism of these diseases. To understand...
2.
Pelyhe C, Sturve J
Fish Physiol Biochem
. 2023 Oct;
49(6):1199-1214.
PMID: 37870723
Extracellular vesicles (EVs) are 50-1,000 nm lipid bilayer-bound vesicles, released into the extracellular environment by various cell types for intercellular communication purposes. The quantitative and qualitative characteristics of EVs can...
3.
Onodi Z, Visnovitz T, Kiss B, Hambalko S, Koncz A, Agg B, et al.
J Mol Cell Cardiol
. 2021 Dec;
165:19-30.
PMID: 34959166
Background: Cardiac cell lines and primary cells are widely used in cardiovascular research. Despite increasing number of publications using these models, comparative characterization of these cell lines has not been...
4.
Jelemensky M, Kovacshazi C, Ferenczyova K, Hofbauerova M, Kiss B, Pallinger E, et al.
Int J Mol Sci
. 2021 Oct;
22(19).
PMID: 34638845
Helium inhalation induces cardioprotection against ischemia/reperfusion injury, the cellular mechanism of which remains not fully elucidated. Extracellular vesicles (EVs) are cell-derived, nano-sized membrane vesicles which play a role in cardioprotective...
5.
Pecan P, Hambalko S, Ha V, Nagy C, Pelyhe C, Lainscek D, et al.
Int J Mol Sci
. 2020 Oct;
21(20).
PMID: 33081396
Cardioprotection against ischemia/reperfusion injury is still an unmet clinical need. The transient activation of Toll-like receptors (TLRs) has been implicated in cardioprotection, which may be achieved by treatment with blood-derived...
6.
Kovesi B, Kulcsar S, Zandoki E, Szabo-Fodor J, Mezes M, Balogh K, et al.
Fish Physiol Biochem
. 2020 Jul;
46(6):1921-1932.
PMID: 32617788
The effects of a single oral dose of 1.82 mg kg bw of T-2 and HT-2 toxin (T-2), 1.75 mg kg bw deoxynivalenol (DON) and 15-acetyl DON, 1.96 mg kg...
7.
Kovesi B, Pelyhe C, Zandoki E, Mezes M, Balogh K
J Anim Physiol Anim Nutr (Berl)
. 2020 Mar;
104(5):1531-1539.
PMID: 32166807
The purpose of the present study was to evaluate the short-term effects of aflatoxin B (AFB ) and deoxynivalenol (DON) exposure on the expression of the genes encoding the glutathione...
8.
Kovesi B, Pelyhe C, Zandoki E, Mezes M, Balogh K
Toxicon
. 2019 Mar;
161:50-56.
PMID: 30849453
Sterigmatocystin (STC) is structurally close to the mycotoxin aflatoxin B as it shares its biosynthetic pathway with aflatoxins. The purpose of the present study was to investigate the short-term (24 ...
9.
Onodi Z, Pelyhe C, Nagy C, Brenner G, Almasi L, Kittel A, et al.
Front Physiol
. 2018 Nov;
9:1479.
PMID: 30405435
Extracellular vesicles (EVs) (isolated from blood plasma) are currently being extensively researched, both as biomarkers and for their therapeutic possibilities. One challenging aspect to this research is the efficient isolation...
10.
Pelyhe C, Kovesi B, Zandoki E, Kovacs B, Erdelyi M, Kulcsar S, et al.
Toxicon
. 2018 Sep;
153:53-57.
PMID: 30170167
Co-occurrence of mycotoxin contamination of feeds is a frequent problem, therefore the purpose of this study was to evaluate the combined effect of T-2 toxin and deoxynivalenol (DON) on lipid...